PEDIATRIX MEDICAL GROUP INC (MD)
US58502B1061 - Common Stock
ChartMill assigns a Buy % Consensus number of 49% to MD. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 9.25. This target is 2.35% above the current price.
MD was analyzed by 17 analysts. The buy percentage consensus is at 49. So analysts seem to be rather neutral about MD.
In the previous month the buy percentage consensus was at a similar level.
MD was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-03-06 | Jefferies | Maintains | Hold -> Hold |
| 2024-02-21 | Mizuho | Maintains | Neutral -> Neutral |
| 2024-02-21 | Truist Securities | Maintains | Hold -> Hold |
| 2023-11-30 | UBS | Initiate | Neutral |
| 2023-10-11 | Truist Securities | Maintains | Hold -> Hold |
| 2023-05-09 | Truist Securities | Maintains | Hold |
| 2023-02-22 | Credit Suisse | Maintains | Outperform |
| 2022-12-05 | Credit Suisse | Maintains | Outperform |
| 2022-11-16 | Mizuho | Maintains | Neutral |
| 2022-11-04 | SVB Leerink | Maintains | Market Perform |
| 2022-08-11 | Credit Suisse | Maintains | Outperform |
| 2022-08-10 | BMO Capital | Maintains | Market Perform |
| 2022-05-12 | SVB Leerink | Maintains | Market Perform |
| 2022-05-03 | Credit Suisse | Maintains | Outperform |
| 2022-05-02 | Mizuho | Maintains | Neutral |
| 2022-04-27 | SVB Leerink | Maintains | Market Perform |
| 2022-02-23 | Credit Suisse | Maintains | Outperform |
| 2021-12-22 | Credit Suisse | Maintains | Outperform |
| 2021-11-04 | SVB Leerink | Maintains | Market Perform |
| 2021-09-27 | SVB Leerink | Initiate | Market Perform |
| 2021-08-09 | Mizuho | Maintains | Neutral |
| 2021-05-24 | Citigroup | Maintains | Neutral |
| 2021-05-10 | Deutsche Bank | Maintains | Sell |
| 2021-02-19 | Credit Suisse | Maintains | Outperform |